Symbols / BJDX
BJDX Chart
About
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. Further, it is developing additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 1.45M |
| Enterprise Value | -2.00M | Income | -6.85M | Sales | — |
| Book/sh | 9.01 | Cash/sh | 6.80 | Dividend Yield | — |
| Payout | 0.00% | Employees | 7 | IPO | — |
| P/E | 0.00 | Forward P/E | -6.41 | PEG | — |
| P/S | — | P/B | 0.23 | P/C | — |
| EV/EBITDA | 0.29 | EV/Sales | — | Quick Ratio | 2.68 |
| Current Ratio | 2.92 | Debt/Eq | 4.15 | LT Debt/Eq | — |
| EPS (ttm) | 657.48 | EPS next Y | -0.32 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-03-28 17:00 | ROA | -65.84% |
| ROE | -126.20% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 708.53K |
| Shs Float | 393.91K | Short Float | 3.63% | Short Ratio | 0.28 |
| Short Interest | — | 52W High | 40.80 | 52W Low | 1.78 |
| Beta | 0.67 | Avg Volume | 187.08K | Volume | 115.69K |
| Target Price | — | Recom | None | Prev Close | $1.94 |
| Price | $2.05 | Change | 5.67% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$2.05
Latest analyst target
3. DCF / Fair value
$-90.26
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.05
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-08-03 | down | Dawson James | Buy → Neutral | — |
- Medical diagnostics firm ends prefunded warrants, flags 13G share confusion - Stock Titan Fri, 20 Feb 2026 11
- ARMISTICE CAPITAL, LLC Acquires Shares in Bluejay Diagnostics Inc - GuruFocus Wed, 25 Feb 2026 06
- Bluejay Diagnostics Announces Full Exercise of Prefunded Warrants and Current Share Structure Update - Quiver Quantitative Fri, 20 Feb 2026 11
- Bluejay Diagnostics says all prefunded warrants exercised; ~972,000 shares outstanding, 1.5M cash-exercise warrants - TradingView Fri, 20 Feb 2026 15
- Bluejay Diagnostics Completes Warrant Exercises, Clarifies Capital Structure - TipRanks Fri, 20 Feb 2026 15
- Bluejay Diagnostics Stock Plummets 37% With 11-Day Losing Streak - Trefis ue, 23 Dec 2025 08
- Sepsis test maker builds supply for 10M rapid kits as key trial advances - Stock Titan ue, 17 Feb 2026 11
- Bluejay Diagnostics stock soars after expanding manufacturing partnership - Investing.com hu, 09 Oct 2025 07
- Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade hu, 09 Oct 2025 14
- Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - Yahoo Finance ue, 27 Jan 2026 08
- Why Etsy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga hu, 19 Feb 2026 09
- Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised - Bitget hu, 19 Feb 2026 19
- $4.5M raise: Bluejay Diagnostics secures private placement to fund FDA approval work - Stock Titan hu, 09 Oct 2025 07
- Bluejay Advances SYMON II Sepsis Study and Manufacturing - TipRanks Wed, 18 Feb 2026 11
- Bluejay Diagnostics Completes 1-for-4 Reverse Stock Split - TipRanks Fri, 30 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -6.70M | -9.17M | -8.77M | -2.98M |
| TotalUnusualItems | 0.00 | -237.31K | 0.00 | |
| TotalUnusualItemsExcludingGoodwill | 0.00 | -237.31K | 0.00 | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -7.72M | -9.95M | -9.30M | -3.49M |
| ReconciledDepreciation | 199.10K | 780.96K | 306.37K | 145.72K |
| ReconciledCostOfRevenue | 0.00 | 200.13K | 0.00 | |
| EBITDA | -6.70M | -9.17M | -9.01M | -2.98M |
| EBIT | -6.89M | -9.95M | -9.32M | -3.12M |
| NetInterestIncome | -677.21K | 164.90K | 89.67K | -367.46K |
| InterestExpense | 823.03K | 0.00 | 0.00 | 367.46K |
| InterestIncome | 145.82K | 164.90K | 89.67K | |
| NormalizedIncome | -7.72M | -9.95M | -9.06M | -3.49M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -7.72M | -9.95M | -9.30M | -3.49M |
| TotalExpenses | 7.17M | 10.31M | 9.57M | 3.16M |
| TotalOperatingIncomeAsReported | -7.17M | -10.31M | -9.32M | -3.23M |
| DilutedAverageShares | 45.85K | 774.00 | 631.00 | 628.00 |
| BasicAverageShares | 45.85K | 774.00 | 631.00 | 628.00 |
| DilutedEPS | -456.76 | -12.86K | -14.73K | -5.55K |
| BasicEPS | -456.76 | -12.86K | -14.73K | -5.55K |
| DilutedNIAvailtoComStockholders | -20.94M | -9.95M | -9.30M | -3.49M |
| NetIncomeCommonStockholders | -20.94M | -9.95M | -9.30M | -3.49M |
| OtherunderPreferredStockDividend | 13.22M | 0.00 | ||
| NetIncome | -7.72M | -9.95M | -9.30M | -3.49M |
| NetIncomeIncludingNoncontrollingInterests | -7.72M | -9.95M | -9.30M | -3.49M |
| NetIncomeContinuousOperations | -7.72M | -9.95M | -9.30M | -3.49M |
| PretaxIncome | -7.72M | -9.95M | -9.30M | -3.49M |
| OtherIncomeExpense | 129.03K | 192.43K | -68.84K | 34.32K |
| OtherNonOperatingIncomeExpenses | 129.03K | 192.43K | 168.46K | 34.32K |
| SpecialIncomeCharges | 0.00 | -237.31K | 0.00 | |
| OtherSpecialCharges | -5.00K | |||
| ImpairmentOfCapitalAssets | 0.00 | 237.31K | 0.00 | |
| GainOnSaleOfSecurity | 9.68K | |||
| NetNonOperatingInterestIncomeExpense | -677.21K | 164.90K | 89.67K | -367.46K |
| InterestExpenseNonOperating | 823.03K | 0.00 | 0.00 | 367.46K |
| InterestIncomeNonOperating | 145.82K | 164.90K | 89.67K | |
| OperatingIncome | -7.17M | -10.31M | -9.32M | -3.16M |
| OperatingExpense | 7.17M | 10.31M | 9.37M | 3.16M |
| OtherOperatingExpenses | -75.00K | |||
| ResearchAndDevelopment | 3.47M | 5.71M | 4.15M | 1.15M |
| SellingGeneralAndAdministration | 3.70M | 4.60M | 5.21M | 2.08M |
| SellingAndMarketingExpense | 8.30K | 283.44K | 451.42K | 289.73K |
| GeneralAndAdministrativeExpense | 3.69M | 4.31M | 4.76M | 1.79M |
| OtherGandA | 3.69M | 4.31M | 4.76M | 1.79M |
| GrossProfit | 0.00 | 48.91K | 0.00 | |
| CostOfRevenue | 0.00 | 200.13K | 0.00 | |
| TotalRevenue | 0.00 | 0.00 | 249.04K | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 249.04K | 0.00 |
| Line Item | 2022-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 138.50K | 774.00 | 631.00 | 628.00 |
| ShareIssued | 138.50K | 774.00 | 631.00 | 628.00 |
| TotalDebt | 222.25K | 352.98K | 492.62K | 0.00 |
| TangibleBookValue | 5.73M | 2.89M | 11.54M | 20.38M |
| InvestedCapital | 5.73M | 2.89M | 11.54M | 20.38M |
| WorkingCapital | 4.09M | 1.45M | 10.15M | 20.02M |
| NetTangibleAssets | 5.73M | 2.89M | 11.54M | 20.38M |
| CapitalLeaseObligations | 222.25K | 352.98K | 492.62K | 0.00 |
| CommonStockEquity | 5.73M | 2.89M | 11.54M | 20.38M |
| TotalCapitalization | 5.73M | 2.89M | 11.54M | 20.38M |
| TotalEquityGrossMinorityInterest | 5.73M | 2.89M | 11.54M | 20.38M |
| StockholdersEquity | 5.73M | 2.89M | 11.54M | 20.38M |
| RetainedEarnings | -34.67M | -26.95M | -17.00M | -7.69M |
| AdditionalPaidInCapital | 40.40M | 29.85M | 28.54M | 28.07M |
| CapitalStock | 55.00 | 0.00 | 101.00 | 2.01K |
| CommonStock | 55.00 | 0.00 | 101.00 | 2.01K |
| TotalLiabilitiesNetMinorityInterest | 927.92K | 1.97M | 1.98M | 637.16K |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 117.56K | 202.31K | 339.74K | 0.00 |
| OtherNonCurrentLiabilities | 8.57K | 12.32K | 15.82K | |
| PreferredSecuritiesOutsideStockEquity | 0.00 | |||
| LongTermDebtAndCapitalLeaseObligation | 108.99K | 189.99K | 323.92K | 0.00 |
| LongTermCapitalLeaseObligation | 108.99K | 189.99K | 323.92K | 0.00 |
| CurrentLiabilities | 810.37K | 1.77M | 1.64M | 637.16K |
| CurrentDebtAndCapitalLeaseObligation | 113.26K | 162.99K | 168.71K | |
| CurrentCapitalLeaseObligation | 113.26K | 162.99K | 168.71K | 0.00 |
| CurrentNotesPayable | 0.00 | |||
| PayablesAndAccruedExpenses | 697.11K | 1.61M | 1.47M | 637.16K |
| CurrentAccruedExpenses | 551.99K | 1.12M | 835.73K | 341.38K |
| Payables | 145.12K | 491.47K | 635.82K | 295.78K |
| DuetoRelatedPartiesCurrent | 2.00K | |||
| AccountsPayable | 145.12K | 491.47K | 635.82K | 295.78K |
| TotalAssets | 6.66M | 4.87M | 13.52M | 21.02M |
| TotalNonCurrentAssets | 1.76M | 1.65M | 1.73M | 358.38K |
| OtherNonCurrentAssets | 35.26K | 28.66K | 35.21K | 21.02K |
| GoodwillAndOtherIntangibleAssets | 4.46K | 4.62K | ||
| OtherIntangibleAssets | 4.46K | 4.62K | ||
| NetPPE | 1.72M | 1.62M | 1.70M | 332.75K |
| AccumulatedDepreciation | -194.95K | -1.24M | -596.41K | -448.84K |
| GrossPPE | 1.92M | 2.86M | 2.29M | 781.58K |
| Leases | 43.23K | 43.23K | 43.23K | 0.00 |
| ConstructionInProgress | 1.35M | 1.05M | 375.47K | 15.08K |
| OtherProperties | 383.06K | 1.62M | 1.73M | 741.59K |
| MachineryFurnitureEquipment | 140.77K | 145.62K | 141.40K | 24.91K |
| BuildingsAndImprovements | 333.27K | 465.51K | ||
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 4.90M | 3.22M | 11.79M | 20.66M |
| OtherCurrentAssets | 85.82K | 51.96K | 240.28K | 1.61M |
| CurrentDeferredAssets | 0.00 | 265.08K | 0.00 | |
| PrepaidAssets | 511.12K | 695.30K | 1.43M | 1.61M |
| Inventory | 0.00 | |||
| CashCashEquivalentsAndShortTermInvestments | 4.30M | 2.21M | 10.11M | 19.05M |
| CashAndCashEquivalents | 4.30M | 2.21M | 10.11M | 19.05M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -8.13M | -9.02M | -8.94M | -4.39M |
| RepaymentOfDebt | -2.00M | -4.81K | -801.00 | -298.62K |
| IssuanceOfDebt | 2.00M | 0.00 | 0.00 | 4.50M |
| IssuanceOfCapitalStock | 12.07M | 1.59M | 0.00 | 18.86M |
| CapitalExpenditure | -306.78K | -704.17K | -1.20M | -23.95K |
| InterestPaidSupplementalData | 1.30K | 364.00 | 150.23K | |
| EndCashPosition | 4.30M | 2.21M | 10.11M | 19.05M |
| BeginningCashPosition | 2.21M | 10.11M | 19.05M | 912.36K |
| ChangesInCash | 2.09M | -7.91M | -8.93M | 18.14M |
| FinancingCashFlow | 10.22M | 1.11M | 8.07K | 22.53M |
| CashFlowFromContinuingFinancingActivities | 10.22M | 1.11M | 8.07K | 22.53M |
| NetOtherFinancingCharges | -1.84M | -474.47K | -20.00K | -562.84K |
| ProceedsFromStockOptionExercised | 558.00 | 0.00 | 28.88K | 31.70K |
| NetPreferredStockIssuance | 0.00 | |||
| PreferredStockIssuance | 0.00 | |||
| NetCommonStockIssuance | 12.07M | 1.59M | 0.00 | 18.86M |
| CommonStockIssuance | 12.07M | 1.59M | 0.00 | 18.86M |
| NetIssuancePaymentsOfDebt | -4.81K | -4.81K | -801.00 | 4.20M |
| NetLongTermDebtIssuance | -4.81K | -4.81K | -801.00 | 4.20M |
| LongTermDebtPayments | -2.00M | -4.81K | -801.00 | -298.62K |
| LongTermDebtIssuance | 2.00M | 0.00 | 0.00 | 4.50M |
| InvestingCashFlow | -306.78K | -704.17K | -1.20M | -23.95K |
| CashFlowFromContinuingInvestingActivities | -306.78K | -704.17K | -1.20M | -23.95K |
| NetPPEPurchaseAndSale | -306.78K | -704.17K | -1.20M | -23.95K |
| PurchaseOfPPE | -306.78K | -704.17K | -1.20M | -23.95K |
| OperatingCashFlow | -7.82M | -8.31M | -7.74M | -4.37M |
| CashFlowFromContinuingOperatingActivities | -7.82M | -8.31M | -7.74M | -4.37M |
| ChangeInWorkingCapital | -633.19K | 666.73K | 578.54K | -1.49M |
| ChangeInOtherWorkingCapital | 265.08K | |||
| ChangeInOtherCurrentAssets | -6.59K | 6.55K | -14.19K | -21.02K |
| ChangeInPayablesAndAccruedExpense | -1.04M | -266.04K | 633.50K | 2.59K |
| ChangeInAccruedExpense | -695.65K | -30.28K | 336.62K | 204.84K |
| ChangeInPayable | -346.35K | -235.76K | 296.88K | -202.25K |
| ChangeInAccountPayable | -346.35K | -235.76K | 298.88K | -79.15K |
| ChangeInPrepaidAssets | 150.32K | 926.22K | -40.77K | -1.55M |
| ChangeInInventory | 0.00 | 84.76K | ||
| ChangeInReceivables | 0.00 | |||
| ChangesInAccountReceivables | 0.00 | |||
| OtherNonCashItems | 308.62K | 1.30K | 222.01K | |
| StockBasedCompensation | 20.09K | 189.25K | 433.00K | 68.46K |
| AssetImpairmentCharge | 1.79K | 237.31K | 0.00 | |
| DepreciationAmortizationDepletion | 199.10K | 780.96K | 306.37K | 145.72K |
| DepreciationAndAmortization | 199.10K | 780.96K | 306.37K | 145.72K |
| Depreciation | 199.10K | 780.96K | 306.37K | 145.72K |
| OperatingGainsLosses | 3.41K | 1.79K | 137.00 | 170.66K |
| GainLossOnInvestmentSecurities | 170.66K | |||
| GainLossOnSaleOfPPE | 3.41K | 1.79K | 137.00 | 0.00 |
| NetIncomeFromContinuingOperations | -7.72M | -9.95M | -9.30M | -3.49M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for BJDX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|